Edition:
United Kingdom

Geron Corp (GERN.OQ)

GERN.OQ on NASDAQ Stock Exchange Global Select Market

1.09USD
17 Jan 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.09
Open
--
Day's High
--
Day's Low
--
Volume
16
Avg. Vol
1,254,255
52-wk High
$6.99
52-wk Low
$0.95

Chart for

About

Geron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company is engaged in the development of therapeutic products for oncology. Using its nucleic acid chemistry,... (more)

Overall

Beta: 2.64
Market Cap(Mil.): $366.19
Shares Outstanding(Mil.): 159.21
Dividend: --
Yield (%): --

Financials

  GERN.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -0.16 -- --
ROI: -21.08 8.99 14.48
ROE: -21.08 10.13 15.99

Earnings vs. Estimates